Insulin resistance is a characteristic feature of noninsulin-dependent diabetes mellitus (NIDDM), in particular when it is associated with obesity. This insulin-resistant state at the peripheral tissue level causes impaired glucose utilization leading to hyperglycemia3 Therefore, amelioration of insulin resistance with a drug would provide a novel and useful means of treating NIDDM. With regard to this concept3s4 few drugs have, however, been